1 | targeting | 4,552 |
2 | transporting | 83 |
3 | banning | 50 |
4 | immunizing | 48 |
5 | amid | 28 |
6 | trialing | 11 |
7 | recycles | 7 |
8 | targetting | 6 |
9 | subsidizing | 5 |
10 | pi-induced | 4 |
11 | ampliseq | 3 |
12 | blocking-out | 3 |
13 | hhcy-induced | 3 |
14 | out-competing | 3 |
15 | 'en | 2 |
16 | -recall | 2 |
17 | adp-liganded | 2 |
18 | adrenomimetic | 2 |
19 | ct-in | 2 |
20 | deflecting | 2 |
21 | mauktikyukta | 2 |
22 | nucleotide-independent | 2 |
23 | pre-inducing | 2 |
24 | treatments.in | 2 |
25 | 'initiate | 1 |
26 | 192/1938 | 1 |
27 | 29-month-old | 1 |
28 | 67g3 | 1 |
29 | 824/982 | 1 |
30 | acrossing | 1 |
31 | administration-proposed | 1 |
32 | administration.given | 1 |
33 | aimedat | 1 |
34 | aminopyrine-n-demethylase | 1 |
35 | aroud | 1 |
36 | array- | 1 |
37 | categories/1000 | 1 |
38 | companies.besides | 1 |
39 | diarrhoeain | 1 |
40 | downmodulates | 1 |
41 | estimated.after | 1 |
42 | factorfor | 1 |
43 | ggti-2133 | 1 |
44 | glyh-101 | 1 |
45 | has-statistically-an | 1 |
46 | hijacks | 1 |
47 | imatinib-mesylate | 1 |
48 | immunization.after | 1 |
49 | impairment-allergy | 1 |
50 | intothe | 1 |
51 | inventory-disengagement | 1 |
52 | iodine-mediated | 1 |
53 | mi-triggered | 1 |
54 | mirclust | 1 |
55 | misconception-in | 1 |
56 | nutlin-3-stimulated | 1 |
57 | opd1 | 1 |
58 | out-number | 1 |
59 | p-800 | 1 |
60 | particle-expressing | 1 |
61 | planning.three | 1 |
62 | porated | 1 |
63 | post-gastrointestinal | 1 |
64 | promoting/maintaining | 1 |
65 | q-vd-oph | 1 |
66 | questionnaire-catastrophizing | 1 |
67 | quing | 1 |
68 | raise-peripheral | 1 |
69 | surgery—including | 1 |
70 | therapies-including | 1 |
71 | toma6 | 1 |
72 | wild‑type | 1 |
1 | 'en | 2 |
2 | 'initiate | 1 |
3 | -recall | 2 |
4 | 192/1938 | 1 |
5 | 29-month-old | 1 |
6 | 67g3 | 1 |
7 | 824/982 | 1 |
8 | acrossing | 1 |
9 | administration-proposed | 1 |
10 | administration.given | 1 |
11 | adp-liganded | 2 |
12 | adrenomimetic | 2 |
13 | aimedat | 1 |
14 | amid | 28 |
15 | aminopyrine-n-demethylase | 1 |
16 | ampliseq | 3 |
17 | aroud | 1 |
18 | array- | 1 |
19 | banning | 50 |
20 | blocking-out | 3 |
21 | categories/1000 | 1 |
22 | companies.besides | 1 |
23 | ct-in | 2 |
24 | deflecting | 2 |
25 | diarrhoeain | 1 |
26 | downmodulates | 1 |
27 | estimated.after | 1 |
28 | factorfor | 1 |
29 | ggti-2133 | 1 |
30 | glyh-101 | 1 |
31 | has-statistically-an | 1 |
32 | hhcy-induced | 3 |
33 | hijacks | 1 |
34 | imatinib-mesylate | 1 |
35 | immunization.after | 1 |
36 | immunizing | 48 |
37 | impairment-allergy | 1 |
38 | intothe | 1 |
39 | inventory-disengagement | 1 |
40 | iodine-mediated | 1 |
41 | mauktikyukta | 2 |
42 | mi-triggered | 1 |
43 | mirclust | 1 |
44 | misconception-in | 1 |
45 | nucleotide-independent | 2 |
46 | nutlin-3-stimulated | 1 |
47 | opd1 | 1 |
48 | out-competing | 3 |
49 | out-number | 1 |
50 | p-800 | 1 |
51 | particle-expressing | 1 |
52 | pi-induced | 4 |
53 | planning.three | 1 |
54 | porated | 1 |
55 | post-gastrointestinal | 1 |
56 | pre-inducing | 2 |
57 | promoting/maintaining | 1 |
58 | q-vd-oph | 1 |
59 | questionnaire-catastrophizing | 1 |
60 | quing | 1 |
61 | raise-peripheral | 1 |
62 | recycles | 7 |
63 | subsidizing | 5 |
64 | surgery—including | 1 |
65 | targeting | 4,552 |
66 | targetting | 6 |
67 | therapies-including | 1 |
68 | toma6 | 1 |
69 | transporting | 83 |
70 | treatments.in | 2 |
71 | trialing | 11 |
72 | wild‑type | 1 |
1 | array- | 1 |
2 | categories/1000 | 1 |
3 | p-800 | 1 |
4 | glyh-101 | 1 |
5 | opd1 | 1 |
6 | 824/982 | 1 |
7 | ggti-2133 | 1 |
8 | 67g3 | 1 |
9 | toma6 | 1 |
10 | 192/1938 | 1 |
11 | mauktikyukta | 2 |
12 | adrenomimetic | 2 |
13 | pi-induced | 4 |
14 | hhcy-induced | 3 |
15 | adp-liganded | 2 |
16 | mi-triggered | 1 |
17 | administration-proposed | 1 |
18 | iodine-mediated | 1 |
19 | nutlin-3-stimulated | 1 |
20 | porated | 1 |
21 | amid | 28 |
22 | 29-month-old | 1 |
23 | aroud | 1 |
24 | planning.three | 1 |
25 | intothe | 1 |
26 | wild‑type | 1 |
27 | aminopyrine-n-demethylase | 1 |
28 | 'initiate | 1 |
29 | imatinib-mesylate | 1 |
30 | pre-inducing | 2 |
31 | therapies-including | 1 |
32 | surgery—including | 1 |
33 | trialing | 11 |
34 | promoting/maintaining | 1 |
35 | banning | 50 |
36 | particle-expressing | 1 |
37 | acrossing | 1 |
38 | deflecting | 2 |
39 | targeting | 4,552 |
40 | out-competing | 3 |
41 | transporting | 83 |
42 | targetting | 6 |
43 | quing | 1 |
44 | subsidizing | 5 |
45 | questionnaire-catastrophizing | 1 |
46 | immunizing | 48 |
47 | q-vd-oph | 1 |
48 | post-gastrointestinal | 1 |
49 | raise-peripheral | 1 |
50 | -recall | 2 |
51 | has-statistically-an | 1 |
52 | 'en | 2 |
53 | administration.given | 1 |
54 | misconception-in | 1 |
55 | ct-in | 2 |
56 | treatments.in | 2 |
57 | diarrhoeain | 1 |
58 | ampliseq | 3 |
59 | out-number | 1 |
60 | estimated.after | 1 |
61 | immunization.after | 1 |
62 | factorfor | 1 |
63 | companies.besides | 1 |
64 | recycles | 7 |
65 | downmodulates | 1 |
66 | hijacks | 1 |
67 | aimedat | 1 |
68 | nucleotide-independent | 2 |
69 | inventory-disengagement | 1 |
70 | mirclust | 1 |
71 | blocking-out | 3 |
72 | impairment-allergy | 1 |